Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Capital Expenditures: 2011-2025

Historic Capital Expenditures for Nutex Health (NUTX) over the last 12 years, with Q3 2025 value amounting to $302000.0.

  • Nutex Health's Capital Expenditures fell 5105.35% to $302000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 5529.9%. This contributed to the annual value of $2.3 million for FY2024, which is 7574.04% down from last year.
  • Nutex Health's Capital Expenditures amounted to $302000.0 in Q3 2025, which was down 5105.35% from $751000.0 recorded in Q2 2025.
  • Nutex Health's 5-year Capital Expenditures high stood at $21.7 million for Q2 2021, and its period low was -$7.9 million during Q4 2022.
  • Moreover, its 5-year median value for Capital Expenditures was $1.8 million (2023), whereas its average is $3.6 million.
  • As far as peak fluctuations go, Nutex Health's Capital Expenditures crashed by 16723.32% in 2022, and later surged by 14782.83% in 2024.
  • Nutex Health's Capital Expenditures (Quarter) stood at $11.7 million in 2021, then crashed by 167.23% to -$7.9 million in 2022, then surged by 89.52% to -$825655.0 in 2023, then skyrocketed by 147.83% to $394897.0 in 2024, then dropped by 23.52% to $302000.0 in 2025.
  • Its Capital Expenditures was $302000.0 in Q3 2025, compared to $751000.0 in Q2 2025 and $64000.0 in Q1 2025.